| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.5M | +12.7% | +22.3% |
| Cost of Revenue | $2.5M | +14.5% | +10.2% |
| Gross Profit | $8.9M | +12.2% | +26.3% |
| R&D Expense | $345K | +77.8% | +114.3% |
| SG&A Expense | $4.8M | +19.1% | +89.0% |
| Operating Income | $1.5M | -21.8% | -24.9% |
| Net Income | $10.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.6M | +13.0% | +194.6% |
| Accounts Receivable | $4.6M | +20.1% | +62.9% |
| Inventory | $6.8M | +15.3% | +98.6% |
| Current Assets | $22.6M | +12.2% | +128.5% |
| Total Assets | $35.6M | +7.7% | +63.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $557K | — | — |
| Capital Expenditures | $1.8M | — | — |
| Investing Cash Flow | $3.2M | — | — |
| Financing Cash Flow | -$4.3M | — | — |
| Free Cash Flow | -$1.3M | — | — |
| +878.7% |
| +150.0% |
| EPS (Basic) | $1.20 | +900.0% | +118.5% |
| EPS (Diluted) | $0.46 | +4500.0% | +107.1% |
| $19.6M |
| -57.9% |
| -76.0% |
| Long-term Debt | $23.3M | — | — |
| Total Liabilities | $38.5M | -19.4% | -53.1% |
| Stockholders' Equity | -$2.9M | +80.2% | +95.1% |